Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant JX-594 in Metastatic Colorectal Tumors Within the Liver
NCT01329809Phase 2Terminated
- Sponsor
- Jennerex Therapeutics
- Start
- Oct 2011
- Primary completion
- Jan 2012
- Countries
- 1
01
Overview
A Phase 2 trial of vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus in colorectal carcinoma (CRC), sponsored by Jennerex Therapeutics. Started Oct 2011; status: terminated.
02
Drugs
vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT01329809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01329809.